Then they transplanted those back into the patient after a severe heart attack (an ST-elevation myocardial infarction, or STEMI)
May 21st, 2024: Ozempic prescriptions reach 9 million as serious side effect reports mount Awareness surrounding Ozempic and other GLP-1 drugs continues to grow
The promise is real, but clinical readiness is not: Preclinical and early human data are compelling, but without large-scale trials, validated delivery methods, and long-term safety data, Epitalon remains an experimental peptide, one to watch closely, but not yet ready for mainstream clinical adoption
BioWorld - Saturday, July 25, 2026 Breaking News: Single-cell transcriptome study points to new drug targets for preeclampsiaSee today's BioWorld Science Home New phase II study begins for GLP-1 agonist AVE-0010 To read the full story, subscribe or sign in